vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and Sprout Social, Inc. (SPT). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $120.9M, roughly 1.0× Sprout Social, Inc.). On growth, Sprout Social, Inc. posted the faster year-over-year revenue change (12.9% vs 4.7%). Sprout Social, Inc. produced more free cash flow last quarter ($9.9M vs $7.6M). Over the past eight quarters, Sprout Social, Inc.'s revenue compounded faster (11.8% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.
NATR vs SPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $123.8M | $120.9M |
| Net Profit | $4.1M | — |
| Gross Margin | 72.5% | 77.6% |
| Operating Margin | 4.3% | -9.0% |
| Net Margin | 3.3% | — |
| Revenue YoY | 4.7% | 12.9% |
| Net Profit YoY | 1379.4% | — |
| EPS (diluted) | $0.23 | $-0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $120.9M | ||
| Q3 25 | $128.3M | $115.6M | ||
| Q2 25 | $114.8M | $111.8M | ||
| Q1 25 | $113.2M | $109.3M | ||
| Q4 24 | $118.2M | $107.1M | ||
| Q3 24 | $114.6M | $102.6M | ||
| Q2 24 | $110.6M | $99.4M | ||
| Q1 24 | $111.0M | $96.8M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $5.3M | $-9.4M | ||
| Q2 25 | $5.3M | $-12.0M | ||
| Q1 25 | $4.7M | $-11.2M | ||
| Q4 24 | $-321.0K | — | ||
| Q3 24 | $4.3M | $-17.1M | ||
| Q2 24 | $1.3M | $-16.9M | ||
| Q1 24 | $2.3M | $-13.6M |
| Q4 25 | 72.5% | 77.6% | ||
| Q3 25 | 73.3% | 77.7% | ||
| Q2 25 | 71.7% | 77.7% | ||
| Q1 25 | 72.1% | 77.3% | ||
| Q4 24 | 72.0% | 78.1% | ||
| Q3 24 | 71.3% | 77.4% | ||
| Q2 24 | 71.4% | 77.5% | ||
| Q1 24 | 71.2% | 76.8% |
| Q4 25 | 4.3% | -9.0% | ||
| Q3 25 | 7.0% | -7.9% | ||
| Q2 25 | 3.7% | -11.0% | ||
| Q1 25 | 5.4% | -10.2% | ||
| Q4 24 | 3.8% | -12.8% | ||
| Q3 24 | 4.6% | -16.4% | ||
| Q2 24 | 5.1% | -16.6% | ||
| Q1 24 | 4.2% | -13.7% |
| Q4 25 | 3.3% | — | ||
| Q3 25 | 4.2% | -8.1% | ||
| Q2 25 | 4.6% | -10.7% | ||
| Q1 25 | 4.2% | -10.3% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 3.8% | -16.6% | ||
| Q2 24 | 1.2% | -17.0% | ||
| Q1 24 | 2.1% | -14.0% |
| Q4 25 | $0.23 | $-0.18 | ||
| Q3 25 | $0.30 | $-0.16 | ||
| Q2 25 | $0.28 | $-0.21 | ||
| Q1 25 | $0.25 | $-0.19 | ||
| Q4 24 | $-0.02 | $-0.25 | ||
| Q3 24 | $0.23 | $-0.30 | ||
| Q2 24 | $0.07 | $-0.30 | ||
| Q1 24 | $0.12 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $95.3M |
| Total DebtLower is stronger | — | $40.0M |
| Stockholders' EquityBook value | $161.6M | $203.4M |
| Total Assets | $261.1M | $523.1M |
| Debt / EquityLower = less leverage | — | 0.20× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $95.3M | ||
| Q3 25 | $95.6M | $90.6M | ||
| Q2 25 | $81.3M | $101.5M | ||
| Q1 25 | $86.5M | $100.9M | ||
| Q4 24 | $84.7M | $86.4M | ||
| Q3 24 | $78.7M | $82.9M | ||
| Q2 24 | $68.7M | $80.9M | ||
| Q1 24 | $77.8M | $69.2M |
| Q4 25 | — | $40.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $25.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $203.4M | ||
| Q3 25 | $166.7M | $194.1M | ||
| Q2 25 | $163.7M | $184.6M | ||
| Q1 25 | $167.1M | $175.3M | ||
| Q4 24 | $161.0M | $166.6M | ||
| Q3 24 | $162.6M | $158.1M | ||
| Q2 24 | $156.4M | $152.1M | ||
| Q1 24 | $159.7M | $147.3M |
| Q4 25 | $261.1M | $523.1M | ||
| Q3 25 | $264.8M | $481.4M | ||
| Q2 25 | $254.9M | $422.9M | ||
| Q1 25 | $252.7M | $424.7M | ||
| Q4 24 | $240.9M | $428.3M | ||
| Q3 24 | $245.3M | $388.8M | ||
| Q2 24 | $235.8M | $393.6M | ||
| Q1 24 | $247.3M | $389.9M |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $10.9M |
| Free Cash FlowOCF − Capex | $7.6M | $9.9M |
| FCF MarginFCF / Revenue | 6.1% | 8.2% |
| Capex IntensityCapex / Revenue | 1.9% | 0.9% |
| Cash ConversionOCF / Net Profit | 2.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $39.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $10.9M | ||
| Q3 25 | $18.5M | $9.3M | ||
| Q2 25 | $4.3M | $5.1M | ||
| Q1 25 | $2.6M | $18.1M | ||
| Q4 24 | $12.2M | $4.1M | ||
| Q3 24 | $9.6M | $9.0M | ||
| Q2 24 | $1.3M | $2.1M | ||
| Q1 24 | $2.2M | $11.2M |
| Q4 25 | $7.6M | $9.9M | ||
| Q3 25 | $16.8M | $8.5M | ||
| Q2 25 | $3.0M | $4.2M | ||
| Q1 25 | $1.5M | $16.7M | ||
| Q4 24 | $10.0M | $3.3M | ||
| Q3 24 | $7.9M | $8.5M | ||
| Q2 24 | $-2.0M | $1.6M | ||
| Q1 24 | $-1.5M | $10.1M |
| Q4 25 | 6.1% | 8.2% | ||
| Q3 25 | 13.1% | 7.4% | ||
| Q2 25 | 2.6% | 3.7% | ||
| Q1 25 | 1.3% | 15.3% | ||
| Q4 24 | 8.5% | 3.0% | ||
| Q3 24 | 6.9% | 8.3% | ||
| Q2 24 | -1.9% | 1.6% | ||
| Q1 24 | -1.4% | 10.4% |
| Q4 25 | 1.9% | 0.9% | ||
| Q3 25 | 1.3% | 0.7% | ||
| Q2 25 | 1.2% | 0.8% | ||
| Q1 25 | 1.0% | 1.2% | ||
| Q4 24 | 1.9% | 0.8% | ||
| Q3 24 | 1.5% | 0.5% | ||
| Q2 24 | 3.0% | 0.5% | ||
| Q1 24 | 3.3% | 1.1% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
SPT
Segment breakdown not available.